Source: Silver Investing News

BioPharma Services: MedReleaf Signs Research Agreement with BioPharma Services

MedReleaf announced an exclusive agreement with BioPharma Services to conduct clinical research for cannabis and its derived product.The post MedReleaf Signs Research Agreement with BioPharma Services appeared first on Investing News Network.

Read full article »
BioPharma Services's Competitors | BioPharma Services's News | BioPharma Services's Financials
Stay up-to-date with the latest news on BioPharma Services Inc.
Est. Annual Revenue
$100K-5.0M
Est. Employees
100-250
Renzo DiCarlo's photo - CEO of BioPharma Services Inc.

CEO

Renzo DiCarlo

CEO Approval Rating

70/100

Read more
Stay up-to-date with the latest news on BioPharma Services Inc.